DMCPA


2,5-Dimethoxy-4-methylphenylcyclopropylamine is a lesser-known psychedelic drug and a substituted amphetamine and phenylcyclopropylamine.

Use and effects

In Alexander Shulgin's book PiHKAL, the dose range is listed as 15 to 20mg and the duration is listed as 4 to 8hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. One of the reports in PiHKAL gave it a +++ on the Shulgin Rating Scale.

Interactions

Pharmacology

Pharmacodynamics

The comprehensive receptor interactions of DMCPA have been studied.

History

DMCPA was first described in the scientific literature by at least 1974.

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.